Related by context. Frequent words. (Click for all words.) 88 Completes Enrollment 87 Presents Positive 86 Initiates Phase 84 Initiate Phase 82 Drug Candidate 81 Announces Initiation 80 Pivotal Phase III 80 Patient Enrollment 80 FDA Accepts 79 Phase III Clinical Trial 79 FDA Clears 79 Receives FDA Clearance 79 Clinical Trial Results 79 Announces FDA Clearance 78 Pivotal Phase 77 Phase III Trial 77 Preclinical Data 77 Announces Publication 77 Develop Novel 77 Inc Therapeutic Competitors 76 Files Shelf Registration Statement 76 Announces Presentation 76 Pivotal Study 75 Pivotal Trial 75 Announces Successful Completion 75 Announces Positive 75 Reports Positive 74 Receives Patent 74 Single Dose 74 FDA Approves 74 Acquires Exclusive 73 Metastatic Melanoma 73 MKC# 73 Achieves Milestone 73 Patent Covering 73 Shows Promise 73 RNAi Therapeutics 73 Small Molecule 73 Generic Version 73 Patent Issued 73 CHEAP ONLINE PHARMACY LOW 72 Receives Positive 72 Study Demonstrates 72 II Clinical Trial 72 Recombinant Human 72 Announces Issuance 72 Q1 Loss Narrows 72 refractory chronic lymphocytic 72 Monoclonal Antibody 72 Chronic Hepatitis C 72 Completes Initial 72 Exercises Option 72 Signs Licensing Agreement 72 Announces Stockholder Approval 72 Secures Financing 72 Receives Regulatory 72 Announces Immediate Availability 71 Announce Collaboration 71 Announces Dismissal 71 Vertex Pharmaceuticals Announces 71 Q3 Loss Widens 71 Q2 Loss Narrows 71 developing Zerenex TM 71 Awarded Patent 71 Secures Additional 71 Inc. Nasdaq IMGN 71 Transcept Pharmaceuticals 71 THERAPEUTICS 71 Q3 Loss Narrows 71 Takeda Kyowa Hakko Kirin 71 please visit http:/www.supergen.com 71 Completes Financing 71 Regains Compliance With 71 Exploit collaboration 71 Cetrorelix 71 Advancing Drugs 70 Phase Ib II 70 Announces Termination 70 Pulmonary Arterial Hypertension 70 Commercialize 70 ThermoDox R 70 Q2 Loss Widens 70 submitted Biologics License 70 Kuvan R 70 Regains Compliance 70 Report companiesandmarkets.com adds 70 Well Tolerated 70 Announces Commencement 70 Updates Status 70 J Am Coll 70 GVAX R 70 Successfully Completes 70 Inc. NASDAQ QLTI 70 Significantly Reduces 70 Microplasmin 70 Q4 Loss Widens 70 Cholesterol Drug 70 Finalizes Acquisition 70 Tesetaxel 70 Panzem R 69 Patients Treated